These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 422952)

  • 21. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
    Evans AE; Kisselbach KD; Yamashiro DJ; Ikegaki N; Camoratto AM; Dionne CA; Brodeur GM
    Clin Cancer Res; 1999 Nov; 5(11):3594-602. PubMed ID: 10589776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma.
    Ikeda H; Nakano G; Nagashima K; Sakamoto K; Harasawa N; Kitamura T; Nakamura T; Nagamachi Y
    Cancer Res; 1987 Jan; 47(1):231-4. PubMed ID: 3791210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
    Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
    Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two new human neuroblastoma cell lines exhibiting tumorigenesis and metastasis in the nude mouse model.
    Fowler CL; Zimmer CC; Ruktanouchai D; Zimmer SG
    Anticancer Res; 1998; 18(3A):1393-8. PubMed ID: 9673346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of four-drug chemotherapy for metastatic neuroblastoma: a pediatric oncology group study.
    Shuster JJ; Land VJ; Nitschke R; Berry DH; Cushing B
    Cancer Treat Rep; 1983 Feb; 67(2):187-8. PubMed ID: 6681732
    [No Abstract]   [Full Text] [Related]  

  • 27. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
    Almgren MA; Henriksson KC; Fujimoto J; Chang CL
    Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correspondence re: Beth Allyson Sheffler, Mary Ann Repman, and Cara-Lynne Schengrund. Development of a neonatal and metastatic murine neuroblastoma model. Cancer Res., 39: 711--713, 1979.
    Lueker DC; Stewart IB; Kainer RA
    Cancer Res; 1979 Aug; 39(8):3277-8. PubMed ID: 455311
    [No Abstract]   [Full Text] [Related]  

  • 29. Staging and treatment of neuroblastoma.
    Evans AE
    Cancer; 1980 Apr; 45(7 Suppl):1799-1802. PubMed ID: 7370930
    [No Abstract]   [Full Text] [Related]  

  • 30. Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma.
    Streck CJ; Zhou J; Ng CY; Zhang Y; Nathwani AC; Davidoff AM
    J Am Coll Surg; 2004 Jul; 199(1):78-86. PubMed ID: 15217634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies and characterization of a murine neuroblastoma model.
    Keogh B; Chu TM; Williams P; Moore RH; Murphy GP
    J Surg Oncol; 1976; 8(6):449-59. PubMed ID: 825682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates in the treatment of neuroblastoma.
    Modak S
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):74-6. PubMed ID: 21326151
    [No Abstract]   [Full Text] [Related]  

  • 33. The final chapter.
    MacPherson CF
    Clin J Oncol Nurs; 2012 Oct; 16(5):E190-1. PubMed ID: 23022946
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.
    Ohnishi Y; Nomura T; Inaba M; Tsuruo T; Sugiyama Y; Ueyama Y
    J Natl Cancer Inst; 1998 Dec; 90(24):1909-11. PubMed ID: 9862631
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy for neuroblastoma: is it all or none?
    Maris JM; Castleberry RP
    J Pediatr Hematol Oncol; 2003 Jul; 25(7):512-4. PubMed ID: 12847315
    [No Abstract]   [Full Text] [Related]  

  • 36. The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
    Masanas M; Masiá N; Suárez-Cabrera L; Olivan M; Soriano A; Majem B; Devis-Jauregui L; Burgos-Panadero R; Jiménez C; Rodriguez-Sodupe P; Boloix A; Toledano I; Guillén G; Navarro A; Llobet-Navas D; Villanueva A; Sánchez de Toledo J; Roma J; Noguera R; Moreno L; Krauss R; Gallego S; Santamaria A; Segura MF
    Clin Transl Med; 2021 Oct; 11(10):e533. PubMed ID: 34709738
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytolytic effects of bromoacetylcholine on neuroblastoma in vitro.
    Chiou CY
    J Pharm Sci; 1975 Mar; 64(3):469-70. PubMed ID: 1171213
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell kinetic-based scheduling of chemotherapy: hypothesis versus reality.
    Hayes FA
    J Clin Oncol; 1987 Nov; 5(11):1713. PubMed ID: 3681366
    [No Abstract]   [Full Text] [Related]  

  • 39. Pediatric cancer forum examines chemotherapy variables.
    Volkers N
    J Natl Cancer Inst; 1991 Dec; 83(23):1714-5. PubMed ID: 1770549
    [No Abstract]   [Full Text] [Related]  

  • 40. Current status of molecular biology and treatment strategy for neuroblastoma.
    Mugishima H
    Int J Clin Oncol; 2012 Jun; 17(3):189. PubMed ID: 22588782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.